+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Regenerative Medicine Market: Analysis By Type (Cell Therapy, Tissue Engineered, Gene Therapy), By Application, By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024)

  • ID: 4832710
  • Report
  • Region: Global
  • 326 pages
  • Azoth Analytics
UP TO OFF
until Dec 31st 2019
1 of 3

FEATURED COMPANIES

  • Amgen
  • Celgene
  • Gilead Sciences
  • MolMed
  • Novartis
  • Orchard Therapeutics
  • MORE
Executive Summary

As stated by the research report published in August 2019, the Global Regenerative Medicine Market was valued at USD 22,814.45 million the year 2018. Driven by a number of differentiated fundamental factors including rise in the prevalence of chronic diseases and increase in medical research investments, the global market for regenerative medicine has been advancing at an augmented pace. The growth has been primarily driven by the search to find permanent cure of large number of incurable diseases such as various autoimmune and metabolic ailments,
cancer, neurodegenerative disorders among others.

Over the recent years, regenerative medicine market has been witnessing considerable growth on the back of rising incidence of chronic diseases, rapidly growing medical research facilities, increasing investment by pharmaceutical manufacturers, and growing government initiatives. In addition, expanding product pipeline of companies and growing number of partnerships and collaborative agreements in this industry is anticipated to fuel the market growth in forecast period. However, high cost associated with the manufacturers and use of regenerative therapy has been hindering market growth.

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of regenerative medicine market. The report analyses the Global Regenerative Medicine Market By Type (Cell Therapy, Gene Therapy, Tissue Engineered) and By Application (Orthopaedic and Dental, Cardiology, Wound Healing, Metabolism and Inflammation, Immunology & Oncology, Others). The global regenerative medicine market has been analyzed By Region (North America, Europe, Asia Pacific, and ROW) and By Country (U.S., Canada, U.K., Germany, France, Italy, China, Japan, India, Brazil) for the historical period of 2014-2018 and the forecast period of 2019-2024.

Scope of the Report

Global Regenerative Medicine Market (Actual Period: 2014-2018, Forecast Period: 2019-2024)
  • Global Regenerative Medicine Market- Size, Growth, Forecast
  • Analysis By Type: Cell Therapy, Gene Therapy, Tissue Engineered.
  • Analysis By Application: Orthopaedic & Dental, Cardiology, Wound Healing, Metabolism & Inflammation, Immunology & Oncology, Others
Regional Regenerative Medicine Market – North America, Europe, Asia Pacific, ROW (Actual Period: 2014-2018, Forecast Period: 2019-2024)
  • Global Regenerative Medicine Market- Size, Growth, Forecast
  • Analysis By Type: Cell Therapy, Gene Therapy, Tissue Engineered.
  • Analysis By Application: Orthopaedic & Dental, Cardiology, Wound Healing, Metabolism & Inflammation, Immunology & Oncology, Others
Country Regenerative Medicine Market – U.S., Canada, Germany, U.K, France, Italy, China, Japan, India, and Brazil (Actual Period: 2014-2018, Forecast Period: 2019-2024)
  • Global Regenerative Medicine Market- Size, Growth, Forecast
  • Analysis By Type: Cell Therapy, Gene Therapy, Tissue Engineered.
  • Analysis By Application: Orthopaedic & Dental, Cardiology, Wound Healing, Metabolism & Inflammation, Immunology & Oncology, Others
Other Report Highlights
  • Competitive Landscape:
  • Company Share Analysis
  • Collaborations, Partnerships and Alliances between Key Industry Players
  • Approved Product Analysis
  • Product Pipeline Analysis
  • Market Dynamics – Drivers and Restraints.
  • Market Trends
  • Porter Five Forces Analysis.
  • SWOT Analysis.
  • Company Analysis – Vericel, Gilead Sciences, Novartis, Spark Therapeutics, Orchard Therapeutics, MolMed, Celgene, Sanofi, Amgen, Shanghai Sunway Biotech.
Customization of the Report
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Amgen
  • Celgene
  • Gilead Sciences
  • MolMed
  • Novartis
  • Orchard Therapeutics
  • MORE

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Regenerative Medicine Market: Product Outlook

5. Global Regenerative Medicine Market : Growth and Forecast
5.1 By Value (2014-2018)
5.2 By Value (2019-2024)

6. Global Regenerative Medicine Market: Segment Analysis
6.1 Global Regenerative Medicine Market Size, By Type: Breakdown (%)
6.1.1 Global Regenerative Medicine Market Size, By Type, 2018 (%)
6.1.2 Global Regenerative Medicine Market Size, By Type, 2024 (%)
6.2 Global Cell Therapy Regenerative Medicine Market, By Value (2014-2024)
6.3 Global Gene Therapy Regenerative Medicine Market, By Value (2014-2024)
6.4 Global Tissue Engineered Regenerative Medicine Market, By Value (2014-2024)
6.5 Market attractiveness of Global Regenerative Medicine Market- By Type
6.6 Global Regenerative Medicine Market Size, By Application: Breakdown (%)
6.6.1 Global Regenerative Medicine Market Size, By Application, 2018 (%)
6.6.2 Global Regenerative Medicine Market Size, By Application, 2024 (%)
6.7 Global Orthopaedic & Dental Regenerative Medicine Market, By Value (2014-2024)
6.8 Global Cardiology Regenerative Medicine Market, By Value (2014-2024)
6.9 Global Wound healing Regenerative Medicine Market, By Value (2014-2024)
6.10 Global Metabolism & Inflammation Regenerative Medicine Market, By Value (2014-2024)
6.11 Global Immunology & Oncology Regenerative Medicine Market, By Value (2014-2024)
6.12 Global Others Regenerative Medicine Market, By Value (2014-2024)
6.1 3 Market attractiveness of Global Regenerative Medicine Market- By Application

7.Global Regenerative Medicine Market: Regional Analysis
7.1 Global Regenerative Medicine Market Size, By Region: Breakdown (%)
7.1.1 Global Regenerative Medicine Market Size, By Region, 2018 (%)
7.1.2 Global Regenerative Medicine Market Size, By Region, 2024 (%)
7.2 North America Regenerative Medicine Market: Growth and Forecast
7.2.1 By Value (2014-2018)
7.2.2 By Value (2019-2024)
7.2.3 North America Regenerative Medicine Market: Competitive Landscape
7.2.4 By Type, By Value (2014-2018)
7.2.5 By Type, By Value (2019-2024)
7.2.6 By Application, By Value (2014-2018)
7.2.7 By Application, By Value (2019-2024)
7.3 North America Regenerative Medicine Market: Country Analysis (U.S and Canada)
7.4 Market Attractiveness of North America Regenerative Medicine Market- By Country
7.4.1 U.S Regenerative Medicine Market, By Value (2014-2024)
7.4.2 U.S Regenerative Medicine Market, By Type, By Value (2014-2018)
7.4.3 U.S Regenerative Medicine Market, By Type, By Value (2019-2024)
7.4.4 U.S Regenerative Medicine Market, By Application, By Value (2014-2018)
7.4. 5U.S Regenerative Medicine Market, By Application, By Value (2019-2024)
7.4.6 Canada Regenerative Medicine Market, By Value (2014-2024)
7.4.7 Canada Regenerative Medicine Market, By Type, By Value (2014-2018)
7.4.8 Canada Regenerative Medicine Market, By Type, By Value (2019-2024)
7.4.9 Canada Regenerative Medicine Market, By Application, By Value (2014-2018)
7.4.10 Canada Regenerative Medicine Market, By Application, By Value (2019-2024)
7.5 Europe Regenerative Medicine Market: Growth and Forecast
7.5.1 By Value (2014-2018)
7.5.2 By Value (2019-2024)
7.5.3 Europe Regenerative Medicine Market: Competitive Landscape
7.5.4 By Type, By Value (2014-2018)
7.5.5 By Type, By Value (2019-2024)
7.5.6 By Application, By Value (2014-2018)
7.5.7 By Application, By Value (2019-2024)
7.6 Europe Regenerative Medicine Market: Country Analysis (U.K, Germany, France, Italy)
7.7 Market Attractiveness of Europe Regenerative Medicine Market- By Country
7.7.1 U.K Regenerative Medicine Market, By Value (2014-2024)
7.7.2 U.K Regenerative Medicine Market, By Type, By Value (2014-2018)
7.7.3 U.K Regenerative Medicine Market, By Type, By Value (2019-2024)
7.7.4 U.K Regenerative Medicine Market, By Application, By Value (2014-2018)
7.7.5 U.K Regenerative Medicine Market, By Application, By Value (2019-2024)
7.5.6 Germany Regenerative Medicine Market, By Value (2014-2024)
7.5.7 Germany Regenerative Medicine Market, By Type, By Value (2014-2018)
7.5.8 Germany Regenerative Medicine Market, By Type, By Value (2019-2024)
7.5.9 Germany Regenerative Medicine Market, By Application, By Value (2014-2018)
7.5.10 Germany Regenerative Medicine Market, By Application, By Value (2019-2024)
7.5.11 France Regenerative Medicine Market, By Value (2014-2024)
7.5.12 France Regenerative Medicine Market, By Type, By Value (2014-2018)
7.5.13 France Regenerative Medicine Market, By Type, By Value (2019-2024)
7.5.14 France Regenerative Medicine Market, By Application, By Value (2014-2018)
7.5.15 France Regenerative Medicine Market, By Application, By Value (2019-2024)
7.5.16 Italy Regenerative Medicine Market, By Value (2014-2024)
7.5.17 Italy Regenerative Medicine Market, By Type, By Value (2014-2018)
7.5.18 Italy Regenerative Medicine Market, By Type, By Value (2019-2024)
7.5.19 Italy Regenerative Medicine Market, By Application, By Value (2014-2018)
7.5.20 Italy Regenerative Medicine Market, By Application, By Value (2019-2024)
7.6 APAC Regenerative Medicine Market: Growth and Forecast
7.6.1 By Value (2014-2018)
7.6.2 By Value (2019-2024)
7.6.3 APAC Regenerative Medicine Market: Competitive Landscape
7.6.4 By Type, By Value (2014-2018)
7.6.5 By Type, By Value (2019-2024)
7.6.6 By Application, By Value (2014-2018)
7.6.7By Application, By Value (2019-2024)
7.7 APAC Regenerative Medicine Market: Country Analysis (Japan, India, China)
7.8 Market Attractiveness of APAC Regenerative Medicine Market- By Country
7.8.1 India Regenerative Medicine Market, By Value (2014-2024)
7.8.2 India Regenerative Medicine Market, By Type, By Value (2014-2018)
7.8.3 India Regenerative Medicine Market, By Type, By Value (2019-2024)
7.8.4 India Regenerative Medicine Market, By Application, By Value (2014-2018)
7.8.5 India Regenerative Medicine Market, By Application, By Value (2019-2024)
7.8.6 Japan Regenerative Medicine Market, By Value (2014-2024)
7.8.7 Japan Regenerative Medicine Market, By Type, By Value (2014-2018)
7.8.8 Japan Regenerative Medicine Market, By Type, By Value (2019-2024)
7.8.9 Japan Regenerative Medicine Market, By Application, By Value (2014-2018)
7.8.10 Japan Regenerative Medicine Market, By Application, By Value (2019-2024)
7.8.11 China Regenerative Medicine Market, By Value (2014-2024)
7.8.12 China Regenerative Medicine Market, By Type, By Value (2014-2018)
7.8.13 China Regenerative Medicine Market, By Type, By Value (2019-2024)
7.8.14 China Regenerative Medicine Market, By Application, By Value (2014-2018)
7.8.15 China Regenerative Medicine Market, By Application, By Value (2019-2024)
7.9 ROW Regenerative Medicine Market: Growth and Forecast
7.9.1 By Value (2014-2018)
7.9.2 By Value (2019-2024)
7.9.4 By Type, By Value (2014-2018)
7.9.5 By Type, By Value (2019-2024)
7.9.6 By Application, By Value (2014-2018)
7.9.7 By Application, By Value (2019-2024)
7.9.8 ROW Regenerative Medicine Market: Country Analysis (Brazil)
7.9.9 Brazil Regenerative Medicine Market, By Value (2014-2024)
7.9.10 Brazil Regenerative Medicine Market, By Type, By Value (2014-2018)
7.9.11 Brazil Regenerative Medicine Market, By Type, By Value (2019-2024)
7.9.12 Brazil Regenerative Medicine Market, By Application, By Value (2014-2018)
7.9.13 Brazil Regenerative Medicine Market, By Application, By Value (2019-2024)

8. Global Regenerative Medicine Market: Competitive Landscape
8.1 Market share of Leading Global Companies
8.2 Global Regenerative Medicine Market : Collaborations, Partnerships and Alliances
8.3 Global Regenerative Medicine Market: Approved Products
8.4 Global Regenerative Medicine Market: Pipeline Products

9. Global Regenerative Medicine Market Dynamics
9.1 Global Regenerative Medicine Market Drivers
9.1.1 Rapid Medical Research Infrastructure Development
9.1.2 Increase in prevalence of chronic and autoimmune diseases
9.1.3 Growing government expenditure in regenerative medicine research
9.2 Global Regenerative Medicine Market Restraints
9.2.1 High cost associated with regenerative medicines
9.3 Global Regenerative Medicine Market Trend
9.3.1 Emerging CAR-T cell therapy
9.3.2 3-D Bioprinting of tissues and organs

10.Porter Five Force Analysis

11.SWOT Analysis

12.Policy and Regulatory Landscape

13.Company Profiles
13.1 Vericel Corporation
13.2 Gilead Sciences
13.3 Novartis
13.4 Spark Therapeutics
13.5 Orchard Therapeutics
13.6 Shanghai Sunway Biotech Co. Ltd.
13.7 MolMed
13.8 Celgene
13.9 Sanofi
13.10 Amgen

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Vericel
  • Gilead Sciences
  • Novartis
  • Spark Therapeutics
  • Orchard Therapeutics
  • MolMed
  • Celgene
  • Sanofi
  • Amgen
  • Shanghai Sunway Biotech.
Note: Product cover images may vary from those shown
Adroll
adroll